Australia markets closed

ZY Jan 2023 55.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.20000.0000 (0.00%)
As of 07:49AM EDT. Market open.
Full screen
Previous close1.2000
Open1.2000
Bid0.0500
Ask2.4500
Strike55.00
Expiry date2023-01-20
Day's range1.2000 - 1.2000
Contract rangeN/A
Volume30
Open interest31
  • Motley Fool

    Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future

    Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.

  • PR Newswire

    Ginkgo to Acquire Zymergen

    Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen stockholders will receive a